Cancer Research AACR Legacy  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marra, G.
Right arrow Articles by Jiricny, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marra, G.
Right arrow Articles by Jiricny, J.
[Cancer Research 61, 7719-7721, November 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Phenotypic Analysis of hMSH2 Mutations in Mouse Cells Carrying Human Chromosomes1

Giancarlo Marra, Stefania D’Atri, Hai Yan, Claudia Perrera, Elda Cannavo’, Bert Vogelstein and Josef Jiricny2

Institute of Medical Radiobiology, University of Zürich and Paul Scherrer Institute, CH-8008 Zürich, Switzerland [G. M., C. P., J. J.]; Istituto Dermopatico dell’Immacolata, 00167 Rome, Italy [S. D., E. C.]; and Howard Hughes Medical Institute, The Oncology Center, Johns Hopkins University, Baltimore, Maryland 21231 [H. Y., B. V.]

Conversion of diploidy to haploidy is a method that allows the generation of stable murine/human hybrid cell lines carrying selected human chromosomes in only a single copy. In this setting, it is possible to detect genetic mutations with greater sensitivity and reliability than in diploid cells. Using this method, we were able to identify mutations in the human mismatch repair (MMR) gene hMSH2 in hereditary nonpolyposis colon cancer families, which have escaped detection by the conventional methods. In this report, we show that such hybrid cell lines can also be a valuable tool in the study of the mutated MMR proteins, in particular the variants found in hereditary nonpolyposis colon cancer families that carry missense mutations and where it is unclear whether they predispose to colon cancer. This analysis is made possible by the fact that the human hMSH2 protein is able to complement the MMR defect in the host murine cell line.




This article has been cited by other articles:


Home page
JAMAHome page
G. Casey, N. M. Lindor, N. Papadopoulos, S. N. Thibodeau, J. Moskow, S. Steelman, C. H. Buzin, S. S. Sommer, C. E. Collins, M. Butz, et al.
Conversion Analysis for Mutation Detection in MLH1 and MSH2 in Patients With Colorectal Cancer
JAMA, February 16, 2005; 293(7): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Tomer, A. B. Buermeyer, M. M. Nguyen, and R. M. Liskay
Contribution of Human Mlh1 and Pms2 ATPase Activities to DNA Mismatch Repair
J. Biol. Chem., June 7, 2002; 277(24): 21801 - 21809.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.